Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model

Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota

(2014) Grace S. Crowther et al.   PLoS One

Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure

(2013) C. H. Chilton et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Role of Rifampin against Propionibacterium acnes BiofilmIn Vitroand in an Experimental Foreign-Body Infection Model

(2012) Ulrika Furustrand Tafin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials

(2012) Derrick W. Crook et al.   CLINICAL INFECTIOUS DISEASES

Biofilm-growing intestinal anaerobic bacteria

(2012) Gianfranco Donelli et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

TheClostridium difficile spo0AGene Is a Persistence and Transmission Factor

(2012) Laura J. Deakin et al.   INFECTION AND IMMUNITY

Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model

(2012) C. H. Chilton et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection

(2012) G. S. Crowther et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Multiple Factors Modulate Biofilm Formation by the Anaerobic Pathogen Clostridium difficile

(2012) T. Thapa et al.   JOURNAL OF BACTERIOLOGY

Levels of Germination Proteins in Dormant and Superdormant Spores of Bacillus subtilis

(2012) S. Ghosh et al.   JOURNAL OF BACTERIOLOGY

Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection

(2012) P.N. Wiegand et al.   JOURNAL OF HOSPITAL INFECTION

Characterisation of Clostridium difficile Biofilm Formation, a Role for Spo0A

(2012) Lisa F. Dawson et al.   PLoS One

In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea

(2011) Jeong-Ok Cha et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Superdormant Spores of Bacillus Species Germinate Normally with High Pressure, Peptidoglycan Fragments, and Bryostatin

(2010) J. Wei et al.   JOURNAL OF BACTERIOLOGY

Economic healthcare costs of Clostridium difficile infection: a systematic review

(2010) S.S. Ghantoji et al.   JOURNAL OF HOSPITAL INFECTION

Triggering Germination Represents a Novel Strategy to Enhance Killing of Clostridium difficile Spores

(2010) Michelle M. Nerandzic et al.   PLoS One

Antibiotic Treatment of Clostridium difficile Carrier Mice Triggers a Supershedder State, Spore-Mediated Transmission, and Severe Disease in Immunocompromised Hosts

(2009) T. D. Lawley et al.   INFECTION AND IMMUNITY

Mecillinam: a low-risk antimicrobial agent for induction of Clostridium difficile infection in an in vitro human gut model

(2009) S. D. Baines et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Superdormant Spores of Bacillus Species Have Elevated Wet-Heat Resistance and Temperature Requirements for Heat Activation

(2009) S. Ghosh et al.   JOURNAL OF BACTERIOLOGY

Low concentrations of vancomycin stimulate biofilm formation in some clinical isolates of Staphylococcus epidermidis

(2009) J S Cargill et al.   JOURNAL OF CLINICAL PATHOLOGY

Control of cell fate by the formation of an architecturally complex bacterial community

(2008) H. Vlamakis et al.   GENES & DEVELOPMENT

Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin

(2008) Karen Smith et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model

(2008) S. D. Baines et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model

(2008) S. D. Baines et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY